Healthcare-associated infections among neonates in Brazil

Infect Control Hosp Epidemiol. 2004 Sep;25(9):772-7. doi: 10.1086/502475.

Abstract

Objective: To describe the epidemiology of healthcare-associated infections (HAIs) among neonates.

Design: Prospective surveillance of HAIs was conducted during 2 years. Infections beginning within 48 hours of birth were defined as HAIs of maternal origin. Death occurring during an active episode of HAI was considered related to HAI.

Setting: Seven neonatal units located in three Brazilian cities.

Patients: All admitted neonates were included and observed until discharge.

Results: Twenty-two percent of 4,878 neonates had at least one HAI. The overall incidence density was 24.9 per 1,000 patient-days, and 28.1% of all HAIs were maternally acquired. HAI rates ranged from 12.3% in the group with a birth weight (BW) of more than 2,500 g to 51.9% in the group with a BW of 1,000 g or less. The main HAIs were bloodstream infection (BSI) and pneumonia. Coagulase-negative staphylococci, Enterobacter species, Staphylococcus aureus, and Klebsiella pneumoniae were the main pathogens. Forty percent of all deaths were related to HAI. Central venous catheter (CVC)-associated BSIs per 1,000 CVC-days ranged from 17.3 (BW, 1,501 to 2,500 g; device utilization [DU], 0.11) to 34.9 (BW, < or = 1,000 g; DU, 34.92). Ventilator-associated pneumonia per 1,000 ventilator-days ranged from 7.0 (BW, < or = 1,000 g; DU, 0.34) to 9.2 (BW, 1,001 to 1,500 g; DU, 0.14).

Conclusions: The high proportion of HAIs of maternal origin highlights perinatal care issues in Brazil and the need to improve the diagnosis of neonatal HAIs. The very low BW group and device-associated infections should be priorities for prevention strategies in this population.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brazil / epidemiology
  • Catheterization, Central Venous / adverse effects
  • Cross Infection / epidemiology*
  • Cross Infection / etiology
  • Cross Infection / microbiology
  • Cross Infection / prevention & control
  • Humans
  • Incidence
  • Infant, Newborn
  • Infant, Premature*
  • Intensive Care Units, Neonatal / statistics & numerical data
  • Population Surveillance
  • Prospective Studies
  • Respiration, Artificial / adverse effects
  • Risk Factors